Members of a global leader in pioneering advanced, targeted pharmaceutical, diagnostic and therapeutic solutions for both human and veterinary medicine, enhancing the quality of life and well-being of our patients while fostering trust, innovation, and responsible care in all communities we serve.
Meeting Global Healthcare Needs
Our products include a wide variety of cancer drugs used by leading oncologists in the treatment of some of the most common forms of cancer.
Changing lives for the better.
Clovis Davis Pharmaceuticals is a leading provider of oncology drugs and diagnostic tests for cancer and women’s health conditions in Uganda and beyond.
David Knott
President
A 30+ year healthcare industry veteran, with multiple start-ups and corporate development experience globally. Having consulted with major hospital groups as well as individual physicians, David has the experience to help you select the right location for your clinical specialty, pull together the local demographics emphasizing the patient service needs in your community, and then coupling it with the best equipment and treatment strategies to optimize your success.
Jeff Reichman
COO
Jeff is an accomplished healthcare executive with extensive experience in pharmaceuticals, healthcare operations, and business development. Currently, he serves as the Chief Operating Officer at Clovis Davis Pharmaceuticals, where he leads strategic initiatives, operations, and global product distribution. His expertise includes forging impactful business partnerships, designing user-centered solutions, and ensuring regulatory compliance. Jeff is also the COO and President of Consulting Services at KKM Global Healthcare Group, a multidisciplinary firm focused on healthcare business development worldwide. Additionally, he serves as Director and Board Secretary at DermaCure RT/Radiance RT, a company specializing in radiation therapy and treatments for conditions such as skin cancer, osteoarthritis, plantar fasciitis, tendonitis, and other inflammatory diseases. Jeff holds a Bachelor of Science in Public Health from Indiana University and a Master’s in Health Administration from St. Louis University.
Mujahid (Jed) Ali
President
Jed Ali is a performance driven pharmaceutical executive, with over 22 years of demonstrated sales, drug research led, and operational initiatives, excelling in a range of key roles across corporate pharma, and through running of his own specialty pharmaceutical businesses. Jed has gained exceptional strategic appreciation, with a proven track-record of gaining market share, achieved through implementation of innovative sales strategies, by influencing key decision makers and stakeholders, resulting in sustainable long-term growth.
Jed started his pharmaceutical career with Merck, and later held several senior positions with Bayer Healthcare, Altana Pharma and Nycomed respectively. Currently Jed serves as the President of Clovis-Davis Pharmaceuticals, USA, a niche specialty pharmaceutical company, focused on launching innovative and novel pharmaceutical and medical testing programs within Cancer Care, Women’s Health, and Wildlife Animal Health, across key global markets in the US, Middle East, and Africa – adding value to stakeholders and ultimately benefiting patients.
Through his extensive industry experience, Jed continues to build sustainable and profitable relationships and business models with customers and stakeholders at all levels, setting and achieving targets and goals, leading by example with a collaborative approach and possessing exceptional interpersonal skills to engage and encourage others through change.
Jed holds a Bachelor of Science, Honors Degree in Biomedical Sciences from Nottingham Trent University, United Kingdom. Jed has also achieved a number of key pharmaceutical industry accolades and accreditations to his name.